TRYP Therapeutics Inc
F:8FW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
TRYP Therapeutics Inc
F:8FW
|
CA |
|
C
|
CIMIC Group Ltd
F:LTH
|
AU |
|
DeFi Development Corp
F:F6S0
|
US |
|
F
|
Full Circle Lithium Corp
XTSX:FCLI
|
CA |
|
U
|
United Rentals Inc
F:UR3
|
US |
|
H
|
HeidelbergCement AG
F:HEI
|
DE |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
A
|
Asana Inc
F:A6N
|
US |
|
H
|
Heineken Holding NV
F:4H5
|
NL |
|
O
|
OUTFRONT Media Inc
F:76C
|
US |
|
A
|
Airbus SE
F:AIR
|
NL |
|
S
|
Svenska Cellulosa SCA AB
XMUN:SCA
|
SE |
|
KLX Energy Services Holdings Inc
NASDAQ:KLXE
|
US |
|
A
|
Abbvie Inc
BMV:ABBV
|
US |
|
Z
|
Zoetis Inc
XMUN:ZOE
|
US |
|
E
|
electroCore, Inc.
F:43E
|
US |
|
R
|
Reach PLC
F:MRR
|
UK |
|
F
|
Fortive Corp
SWB:F03
|
US |
|
H
|
Hasbro Inc
DUS:HAS
|
US |
|
K
|
KDDI Corp
XBER:DIP
|
JP |
|
Memex Inc
XTSX:OEE
|
CA |
|
C
|
Close Brothers Group PLC
OTC:CBGPY
|
UK |
|
B
|
B&M European Value Retail SA
OTC:BMRPF
|
LU |
Bankruptcy Probability
TRYP Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
TRYP Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
T
|
TRYP Therapeutics Inc
CNSX:TRYP
|
5.8m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
963.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
212.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
TRYP Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, TRYP Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
